https://sanuwave.com/ 2025-09-18T07:27:53+00:00 1.00 https://sanuwave.com/clinical 2025-09-18T07:27:53+00:00 0.80 https://sanuwave.com/products/ 2025-09-18T07:27:53+00:00 0.80 https://sanuwave.com/products/ultramist/ 2025-09-18T07:27:53+00:00 0.80 https://sanuwave.com/products/dermapace/ 2025-09-18T07:27:53+00:00 0.80 https://sanuwave.com/investors/management-team 2025-09-18T07:27:53+00:00 0.80 https://sanuwave.com/investors/board-of-directors 2025-09-18T07:27:53+00:00 0.80 https://sanuwave.com/investors/press-releases 2025-09-18T07:27:53+00:00 0.80 https://sanuwave.com/investors/events 2025-09-18T07:27:53+00:00 0.80 https://sanuwave.com/contact 2025-09-18T07:27:53+00:00 0.80 https://sanuwave.com/providers 2025-09-18T07:27:53+00:00 0.80 https://sanuwave.com/products/ultramist/clinical-data/ 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/products/orthopace/ 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/data/documents/Sanuwave_UltraMist_MOA_Inflammation_insert.pdf 2025-09-17T17:46:04+00:00 0.64 https://sanuwave.com/data/documents/Sanuwave_UltraMist_MOA_Vasodilation_insert.pdf 2025-09-17T17:46:04+00:00 0.64 https://sanuwave.com/data/documents/Sanuwave_UltraMist_MOA_Bacteria_insert.pdf 2025-09-17T17:46:04+00:00 0.64 https://sanuwave.com/products/dermapace/clinical-data/ 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/investors/alerts 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/investors/presentations 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/investors/videos 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/investors/governance 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/investors/chart 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/investors/sec-filings 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/investors/investor-info 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/investors/ 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/products/ultramist/clinical-data/clinical-summary 2025-09-18T07:27:53+00:00 0.64 https://sanuwave.com/data/documents/SNWV-Corporate-Governance-Guidelines-03-25-1.pdf 2025-09-17T17:46:04+00:00 0.51 https://sanuwave.com/data/documents/Transfer%20Agent%20Info%20for%20Shareholders%20Post-Reverse%20Stock%20Split.pdf 2025-09-17T17:46:04+00:00 0.51 https://sanuwave.com/data/documents/f8937%20-%20SNWV.pdf 2025-09-17T17:46:04+00:00 0.51